Showing 61 - 80 results of 15,188 for search '(((( 50 ((ng decrease) OR (we decrease)) ) OR ( 51 0 decrease ))) OR ( 50 ms decrease ))', query time: 0.52s Refine Results
  1. 61
  2. 62
  3. 63
  4. 64
  5. 65

    Table_1_Decreased Serum Brain-Derived Neurotrophic Factor Concentrations 72 Hours Following Marathon Running.DOCX by Astrid Roeh (11136600)

    Published 2021
    “…</p><p>Results: Linear mixed-model analyses revealed a main effect of time for BDNF concentrations over the study period (F<sub>(4,89.389)</sub> = 4.296, p = 0.003). Values decreased significantly with the lowest values at 72 h after the marathon compared to baseline (p = 0.025), a finding that was more pronounced in the larger male cohort.…”
  6. 66
  7. 67

    DART-ID decreases missing datapoints across runs. by Albert Tian Chen (6900215)

    Published 2019
    “…Only peptides seen in >50% of experiments are included. (<b>b</b>) Decrease in missing data across all runs after applying DART-ID, for SCoPE-MS and the two bulk sets from <a href="http://www.ploscompbiol.org/article/info:doi/10.1371/journal.pcbi.1007082#pcbi.1007082.g004" target="_blank">Fig 4</a> at 1% FDR. …”
  8. 68

    ngLVA degradation kinetics. by Nicole A. Grieshaber (11175417)

    Published 2022
    “…<p>Cos-7 cell infected with L2-euoprom-ngLVA, treated with 34 μg/ml chloramphenicol (CAM) or vehicle only (1:1000 EtOH in RPMI) at 35 hpi (arrow). …”
  9. 69
  10. 70
  11. 71
  12. 72
  13. 73

    Neural networks classify states which differ in neuronal activity levels using ensembles of neurons that increase/decrease their activity in each state. by Nicholas A. Frost (10739821)

    Published 2021
    “…<p><b>(A)</b> In this case, the State B raster was generated from the State A raster by shifting activity from neurons 1–50 to neurons 51–100. As a result, there is an increase (neurons 51:100) or decrease (neurons 1:50) in activity levels in State B compared to State A. …”
  14. 74
  15. 75
  16. 76
  17. 77

    Identification, Synthesis, and Biological Evaluations of Potent Inhibitors Targeting Type I Protein Arginine Methyltransferases by Xiao Li (107004)

    Published 2022
    “…CARM1 (coactivator-associated arginine methyltransferase 1), which belongs to type I PRMTs (protein arginine methyltransferases), is a potential therapeutic target for treatment of multiple cancers. In this study, we first identified several hit compounds against CARM1 by structure-based virtual screening (IC<sub>50</sub> = 35.51 ± 6.68 to 68.70 ± 8.12 μM) and then carried out chemical structural optimizations, leading to six compounds with significantly improved activities targeting CARM1 (IC<sub>50</sub> = 18 ± 2 to 107 ± 6 nM). …”
  18. 78
  19. 79
  20. 80